• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

PN401 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5756702

PN-401 is a synthetic uridine pro-drug that is converted to uridine in vivo. Uridine, a pyrimidine nucleotide, has been used in a variety of diseases including depressive disorders and inherited myopathies. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
PN401, Inhibitor
Full Product Name
PN401
Product Gene Name
Product Synonym Names
RG2133; RG 2133; RG-2133; PN 401; PN-401; PN-401
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
370.31
Solubility
Water: Insoluble
DMSO: Soluble
(<1mg/ refers to the product slightly soluble or insoluble)
Formula
C15H18N2O9
SMILES
O=C(C=CN1[C@H]2[C@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O2)NC1=O
CAS Number
4105-38-8

Product References and Citations for PN401, inhibitor

Saydoff, Joel A.; Garcia, Rolando A. G.; Browne, Susan E.; Liu, Liansheng; Sheng, Jin; Brenneman, Denise; Hu, Zhongyi; Cardin, Sylvain; Gonzalez, Alexis; von Borstel, Reid W.; Gregorio, Jason; Burr, Holly; Beal, M. Flint. Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease. Neurobiology of Disease (2006), 24(3), 455-465. CODEN: NUDIEM ISSN:0969-9961. CAN 146:266494 AN 2006:1245538
Doroshow, James H.; McCoy, Sheryl; Macdonald, John S.; Issell, Brian F.; Patel, Taral; Cobb, Patrick W.; Yost, Kathleen J.; Abbruzzese, James L. Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: A Southwest Oncology Group study. Investigational New Drugs (2006), 24(6), 537-542. CODEN: INNDDK ISSN:0167-6997. CAN 146:414364 AN 2006:834313
Saif, Muhammad Wasif; Borstel, Reid. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice. Cancer Chemotherapy and Pharmacology (2006), 58(1), 136-142. CODEN: CCPHDZ ISSN:0344-5704. CAN 145:327796 AN 2006:375032
Garcia, Rolando A. G.; Liu, Liansheng; Hu, Zhongyi; Gonzalez, Alexis; von Borstel, Reid W.; Saydoff, Joel A. Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine. Brain Research (2005), 1066(1-2), 164-171. CODEN: BRREAP ISSN:0006-8993. CAN 144:81045 AN 2005:1319808

Other Notes

Small volumes of PN401, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for PN401 purchase

MBS5756702 is an inhibitor targeting PN401.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000